Previous Article | Next Article 
Journal of Virology, July 2000, p. 6015-6020, Vol. 74, No. 13
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Balanced Hemagglutinin and Neuraminidase Activities Are Critical
for Efficient Replication of Influenza A Virus
Lyndon J.
Mitnaul,1,
Mikhail
N.
Matrosovich,1,2
Maria R.
Castrucci,3
Alexander B.
Tuzikov,4
Nikolai V.
Bovin,4
Darwyn
Kobasa,1 and
Yoshihiro
Kawaoka5,6,*
Department of Virology and Molecular Biology, St. Jude
Children's Research Hospital, Memphis, Tennessee
381011; M. P. Chumakov
Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of
Medical Sciences, 142782 Moscow,2 and
Shemyakin Institute of Bioorganic Chemistry, Miklukho-Maklaya,
117871 Moscow,4 Russia; Dipartimento
di Virologia, Istituto Superiore di Sanita, 00161 Rome,
Italy3; Department of
Pathobiological Sciences, School of Veterinary Medicine, University of
Wisconsin
Madison, Madison, Wisconsin
537065; and Institute of Medical
Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan6
Received 13 December 1999/Accepted 6 April 2000
 |
ABSTRACT |
The SD0 mutant of influenza virus A/WSN/33 (WSN), characterized by
a 24-amino-acid deletion in the neuraminidase (NA) stalk, does not grow
in embryonated chicken eggs because of defective NA function.
Continuous passage of SD0 in eggs yielded 10 independent clones that
replicated efficiently. Characterization of these egg-adapted viruses
showed that five of the viruses contained insertions in the NA gene
from the PB1, PB2, or NP gene, in the region linking the transmembrane
and catalytic head domains, demonstrating that recombination of
influenza viral RNA segments occurs relatively frequently. The other
five viruses did not contain insertions in this region but displayed
decreased binding affinity toward sialylglycoconjugates, compared with
the binding properties of the parental virus. Sequence analysis of one
of the latter viruses revealed mutations in the hemagglutinin (HA)
gene, at sites in close proximity to the sialic acid receptor-binding
pocket. These mutations appear to compensate for reduced NA function
due to stalk deletions. Thus, balanced HA-NA functions are necessary for efficient influenza virus replication.
 |
INTRODUCTION |
Influenza A viruses contain eight
segments of negative-sense, single-stranded RNA (reviewed in reference
16). Each RNA segment encodes at least one protein,
and two of these proteins, hemagglutinin (HA) and neuraminidase (NA),
project through the viral envelope and are available for interactions
with cellular molecules. The abundance of each protein varies among
virus subtypes, with the HA-NA ratio of influenza virus A/WSN/33 (H1N1)
being approximately 10 to 1 (21). Since HA and NA recognize
the same molecule (sialic acid) with conflicting activities, it can be
assumed that drastic changes in either activity would affect viral replication.
The HA, a type I integral membrane glycoprotein, is cleaved into two
disulfide-linked chains, HA1 and HA2, by host proteases. Such cleavage
is critical for viral infectivity, because it exposes the membrane
fusion peptide located at the amino terminus of the HA2 subunit
(reviewed in reference 14). The HA functions as a
homotrimer of noncovalently linked monomers and plays two major roles
during the replication of influenza A virus in host cells. First, it
attaches the virus to the cell surface by binding to sialic-acid-containing receptors and promotes viral penetration by
mediating fusion of the endosomal and viral membranes. The conserved
sialic acid receptor-binding pocket, located on the HA1 subunit at the
distal end of the molecule, binds to monovalent sialic acid receptor
analogs with relatively low affinity (dissociation constant,
approximately 0.1 to 1 mM [11]); however, the high abundance of HA molecules on the virion surface permits a sufficient number of low-affinity interactions to allow virus attachment and entry
into host cells.
The NA molecule, a type II integral membrane glycoprotein (7,
28), consists of a box-like catalytic head, a centrally attached
stalk with a hydrophobic transmembrane-spanning region that attaches
the molecule to the plasma and viral membranes, and a cytoplasmic tail
of six amino acids (1). The NA functions as a homotetramer,
facilitating the mobility of virions by removing sialic acid residues
from viral glycoproteins and infected cells during both entry and
release from cells (1, 15, 25). Many studies have documented
that influenza virus particles with low NA enzymatic activity cannot be
efficiently released from infected cells, resulting in the accumulation
of large aggregates of progeny virions on the cell surface (17,
21, 25). Since the formation of aggregates results directly from
HA binding to sialic acid receptors on cellular and viral surfaces, a
balance of competent HA and NA activities appears critical. In brief,
there should be enough HA activity to ensure virus binding and enough
NA activity to ensure the release of progeny virus.
Observing how viruses adapt to restricted conditions in the host can
provide important information on the requirements for efficient viral
replication. In most instances, influenza viruses overcome barriers to
replication by one of three mechanisms: (i) genetic drift (mutations
due to errors introduced by viral polymerase), (ii) genetic shift
(reassortment of RNA segments between two different viruses), and
(iii) RNA-RNA recombination (exchange of genetic information
between RNA segments). Although rarely observed in nature,
examples of RNA-RNA recombination of influenza A viruses have been
documented in the laboratory. Khatchikian et al. (12) discovered 54 nucleotides of the cellular 28S rRNA inserted into the
HA1/HA2 cleavage site, while Orlich et al. (24) found 60 nucleotides of the nucleoprotein (NP) gene within the HA1/HA2 cleavage
site. In each case, the resultant virus had acquired the necessary
alteration for efficient replication in the restrictive host. Moreover,
mutant viruses have been generated by introducing foreign nucleotides
into the NA gene during ribonucleoprotein transfection experiments
(2).
Castrucci et al. (6) and Luo et al. (18)
investigated the biologic importance of the NA stalk by generating WSN
viruses with a complete deletion of the NA stalk region. The virus made by Castrucci et al. (6), designated SD0, grew to the same
titer as wild-type virus on cultured Madin-Darby canine kidney (MDCK) cells; however, it did not grow in embryonated chicken eggs. In these
studies, the length of the NA stalk correlated with growth of the virus
in eggs; also, the longer the NA stalk, the more active NA was in
eluting virions from chicken erythrocytes.
To understand the molecular mechanism by which an influenza virus
compensates for a defect in NA function necessary for growth, we
passaged SD0 virus until it efficiently grew in chicken eggs and
identified the molecular events that occurred during its adaptation.
 |
MATERIALS AND METHODS |
Viruses and cells.
Influenza virus A/WSN/33 (H1N1) (WSN) was
obtained from the repository at St. Jude Children's Research Hospital,
Memphis, Tenn. SD0 virus, which contains a 24-amino-acid deletion of
the NA stalk region, was generated and characterized previously
(6). Madin-Darby bovine kidney (MDBK) cells were maintained
in Eagle's minimal essential medium in the presence of 10% fetal calf
serum. MDCK cells were maintained in Eagle's minimal essential medium in the presence of 5% newborn calf serum.
Passage of SD0 virus in embryonated chicken eggs.
Approximately 107.3 PFU of MDCK cell-grown SD0 virus (1 ml)
was injected into 10-day-old embryonated chicken eggs (done in
duplicate). After incubation at 35°C for 2 days, the egg allantoic
fluid was harvested, clarified, and tested for viral growth by
hemagglutination assays at room temperature, by using 0.5% turkey red
blood cells (tRBCs). Virus was serially passaged by inoculating eggs
with undiluted allantoic fluid until hemagglutination was observed, at
which time the allantoic fluid (100 µl) was injected into eggs in
limiting dilutions (usually 10
1 to 10
5). To
biologically clone the egg-adapted viruses, we plaque assayed the fluid
sample that produced hemagglutination and then picked five separate
plaques. Each plaque was injected into eggs, and hemagglutination
assays were performed to confirm viral growth in eggs. The HA and NA
genes of the egg-adapted viruses (plaques that resulted in
hemagglutination) were sequenced and then grown in MDCK cells to make
stock viruses for further characterization.
NA and HA sequence analysis.
Viral genes from egg- and MDCK
cell-grown viruses were sequenced after the isolation of viral RNA and
cDNA, with 20 U of avian myeloblastosis virus reverse transcriptase
(Life Sciences, Inc.) and 1 µg of Uni12 primer
(5'AGCGAAAGCAGG3', corresponding to viral noncoding
nucleotides 1 to 12 [15]). The HA and NA genes were then amplified by PCR by using 2.5 U of cloned Pfu
polymerase (Stratagene) and were sequenced with specific HA and NA
primers. The viral genes were sequenced by TaqFS Dye
Terminator Chemistry.
PCR verification of NP insertion.
To determine the egg
passage at which NP sequences were inserted into the NA stalk region,
we designed a specific NP reverse primer (NPinsert) corresponding to NP
nucleotides 532 to 551 (5'TACACGAGTGACTACGTCCC3'), representing the NP (antisense) sequences inserted into the NA stalk region (Fig. 1A, italic sequences).
A specific NA forward primer (N1W26), corresponding to the coding
nucleotides 26 to 46 (5'CCATTGGGTCAATCTGTATGG3'), and
NPinsert were then used in PCRs (Pfu polymerase;
Stratagene). Viral RNA was isolated from aliquots of each egg passage
and was used as a template for cDNA synthesis. To confirm RNA isolation
and cDNA synthesis, we used a specific NA reverse primer (N1R836),
corresponding to nucleotides 836 to 817 (5'TCACTTTGCCGGTATCAGGG3'), instead of NPinsert, as a
positive control.


View larger version (2427K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Nucleic acid sequences and the locations of inserts
in the NAs of five SD0 egg-adapted strains. The proposed transmembrane
and catalytic head domains of the NA are indicated. Inserted sequences
are identical to the PB1, PB2, and NP gene segments of WSN virus. The
21EA strain contains NP nucleotides 523 to 586; 18EA contains PB2
nucleotides 928 to 981; 10EA contains PB1 nucleotides 1814 to 1851; 7EA
contains PB1 nucleotides 2063 to 2092; and 0EA contains PB2 nucleotides
720 to 784. Bold italic sequences in 21EA indicate the NP-specific
primer (primer NPinsert) synthesized for PCR detection (see Table 2).
(B) Deduced amino acid sequence and locations of inserted amino acids
in five SD0 egg-adapted strains.
|
|
Glycoprotein incorporation into virions.
MDBK cells were
infected with wild-type or egg-adapted virus, and 4 h later, were
starved of glucose for 30 min and were labeled with 0.2 mCi of
[3H]mannose (Amersham) for 18 h. Virus in the
culture supernatant was purified by centrifugation (1 h) at
130,000 × g through 30% sucrose. The virus pellet was
then disrupted with lysis buffer (50 mM Tris-HCl [pH 7.5], 600 mM
KCl, and 0.5% Triton X-100). Viral proteins were analyzed by sodium
dodecyl sulfate-10% polyacrylamide gel electrophoresis
(13).
Hemagglutination test.
Hemagglutination activity was
determined in microtiter plates by using 0.5% tRBCs. The reactions
were performed in phosphate-buffered saline (PBS), either on ice or at
room temperature (approximately 20°C). To avoid possible destruction
of the sialyloligosaccharide receptors, a 2 µM concentration of the
NA inhibitor zanamivir (2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic
acid, GG167 [29]), kindly provided by R. Bethell
(Research and Development, Glaxo Wellcome), was included in the
reaction mixture.
Assay of virus binding of sialylglycopolymers.
For the
receptor-binding assay, virus in culture fluids was partially purified
by removing cellular debris by low-speed centrifugation prior to
pelleting by high-speed centrifugation. The pelleted viruses were
suspended in 50% glycerol-0.1 M Tris buffer, pH 7.3, and were stored
at
20°C. The general procedure of this solid-phase receptor-binding
assay was described previously (9). The modifications applied in this study included the use of synthetic sialylglycopolymers and a biotin-streptavidin detection system. Monospecific biotinylated sialylglycopolymers bearing pendant Neu5Ac(
2-3)Gal(
1-4)Glc
residues (3'SL-PAA) or Neu5Ac(
2-6)Gal(
1-4)GlcNAc residues
(6'SLN-PAA) were synthesized as previously described (4).
Polyvinyl chloride EIA microplates (Costar) were coated with 5 µg of
bovine fetuin per ml in PBS (50 µl/well) overnight and were washed
with distilled water. The viruses, diluted in PBS to an HA titer of
1/32 to 1/64, were incubated in the wells of fetuin-coated plates (40 µl/well) at 4°C overnight; then the wells were washed with an
ice-cold 0.2× PBS-0.01% Tween 80 solution washing buffer. Serial
twofold dilutions of sialylglycopolymer in the reaction buffer (0.02% bovine serum albumin, 0.01% Tween 80, 1 µM zanamivir in PBS) were added to the wells (20 µl/well), followed by 2 h of incubation at 4°C. After five washings with washing buffer, 25 µl of
streptavidin-peroxidase conjugates (ICN Biomedicals, Inc.), diluted
1/2,000 in reaction buffer, was added to each well, followed by 1 h of incubation at 4°C.
The plates were washed, and the peroxidase activities in the wells were
determined with o-phenylenediamine, which was used as a
chromogenic substrate. The absorbency data were converted to Scatchard
plots graphing A492 per degree centigrade versus A492. Affinity values
(Kaff), formally equivalent to dissociation constants of the virus-sialylglycopolymer complexes, were obtained by
regression analysis of these plots (9). The absolute
Kaff varied in replicate experiments performed
on different days, but the relative affinities of the variants were
highly reproducible, permitting the use of averaged data for this variable.
 |
RESULTS |
Adaptation of SD0 to embryonated chicken eggs.
To determine
the molecular requirements for efficient growth of SD0 in eggs, we
serially passaged the virus in eggs (10 independent lines), as outlined
in Materials and Methods. tRBCs were used because they are more
sensitive than chicken red blood cells to hemagglutination by virus
(unpublished data). Ten viruses capable of hemagglutination activity
were generated after 8 to 12 passages (Table
1), suggesting that the SD0 virus
requires several mutations to grow efficiently in eggs. The
hemagglutination titers varied among the adapted viruses: some had a
hemagglutination titer of only 1:2, while others had titers as high as
1:64. There was no apparent relationship between the hemagglutination
titer and passage number (i.e., viruses that became hemagglutination
positive at later passages did not always produce higher titers than
viruses that became hemagglutination positive earlier).
Sequence analysis of NA genes.
Castrucci et al. (6)
showed that the length of the SD0 NA stalk correlates with improved
viral growth in eggs, prompting us to investigate the NA gene for
molecular changes. Sequence analysis of cDNAs by reverse transcriptase
PCR revealed two types of egg-adapted viruses, one containing
nucleotide insertions in the NA gene and the other containing no
insertions in this gene (Table 1).
Five viruses (0EA, 7EA, 10EA, 18EA, and 21EA) had insertions between
the transmembrane and catalytic head regions of the NA gene (Fig. 1).
The insertions originated from three viral gene segments: PB1, PB2, and
NP. One virus, 0EA, contained 22 amino acids inserted from the PB2 gene
(Fig. 1, nucleotides 720 to 784). Egg-adapted virus 10EA contained
sequences from the PB1 gene (Fig. 1A, 13 amino acids, nucleotides 1814 to 1851). Two other PB2 sequences were inserted into the NA gene (Fig.
1): 10 amino acids for 7EA (nucleotides 2063 to 2092) and 18 amino
acids for 18EA (nucleotides 928 to 981). In addition, 21EA acquired
sequences from the NP gene, resulting in an addition of 21 amino acids
(nucleotides 523 to 586) between the NA transmembrane and catalytic
head regions.
By computer analysis, the inserted nucleotide and amino acid sequences
lacked homology with the wild-type NA stalk sequences (Fig. 1) and with
each other. Of the five insertions, three were in the same open reading
frames of the respective gene segments (10EA, 18EA, and 21EA), while
the remaining two (0EA and 7EA) were not.
PCR detection of NP insertion.
Additional studies focused on
0EA and 21EA, which acquired new NA stalks, and 2EA, which still lacked
an NA stalk. To determine the passage number at which the insertion
occurred, we tested each passage of 21EA for incorporation of NP
sequences by using PCR with a specific primer that corresponded to the
inserted NP sequences (Fig. 1A, 21EA, italic boldface sequences) and an
NA sequence-specific primer. With this combination, we could identify cDNAs containing the NP insertion by the detection of a 0.8-kb PCR
product; the absence of this product indicated that RNA recombination had not yet occurred. Two NA sequence-specific primers were used as a
positive control. Viruses from all passages produced a 0.8-kb band in
the positive control reaction (Table 2),
but only those from the fourth and subsequent passages yielded this
product when the alternative primer was used, suggesting that the NP
insertion had occurred between passages 3 and 4. The lack of
appreciable improvement in viral replication in eggs with the
acquisition of new sequences (recombination event), as judged by
hemagglutination of virus in allantoic fluid, indicated that other
mutations were likely needed to establish productive growth in
embryonated eggs.
Incorporation of recombinant NA molecules into virions.
An
increased number of NA molecules in virions may compensate for the
functional defect in the SD0 NA. To assess the level of incorporation
of NA molecules containing newly acquired foreign sequences (new NA
stalks), we grew egg-adapted viruses on MDBK cells in the presence of
[3H]mannose, followed by purification and analysis by
sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis. Each
recombinant NA molecule was incorporated to the same extent as the NA
of the parental (SD0) virus (data not shown), indicating that insertion of foreign sequences into the NA stalk region does not affect NA incorporation.
Sequence analysis of HA genes.
Influenza A viruses cultivated
in the presence of NA inhibitors contain mutations in their HA genes
(10, 19). Thus, since some egg-adapted viruses did not
contain insertions in the NA, we sequenced and compared the HA genes of
recombinant and nonrecombinant viruses. In addition to an insertion in
the NA gene, 0EA had two mutations in the HA, one in the HA1 region
(asparagine 95 to aspartic acid)(H3 numbering) and one in the HA2
region (asparagine 72 to lysine), while 21EA contained a
valine-135-to-isoleucine change in HA1 (Table
3). 2EA lacked an insertion in the NA
gene but contained three HA mutations, serine 146 to glycine and
arginine 262 to lysine in HA1 and arginine 106 to lysine in HA2.
Figure 2 is a schematic diagram of the
three-dimensional structure of the HA monomer (30),
indicating the location of each mutation in relation to its sialic acid
substrate. As shown, the mutations at residues 135HA1 and 146HA1 are in
close proximity to the receptor binding site, while the mutation at
residue 95HA1 is somewhat farther away, though still in the globular
portion of the HA molecule. Potentially, each mutation could alter the characteristics of HA receptor binding and thus the replicative properties of the virus. Mutations at residues 262HA1, 72HA2, and
106HA2 are more distant from the receptor-binding site; hence, a
contribution of these changes to receptor-binding activity is unlikely.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Three-dimensional structure of the HA monomer
(30), indicating the location of each HA mutation discovered
in three SD0 egg-adapted strains, relative to sialic acid (Neu5Ac)
binding.
|
|
HA receptor-binding properties.
One explanation for the above
results is that HA mutations can compensate for the loss of NA activity
(3, 20). We therefore evaluated the receptor-binding
properties of our egg-adapted viruses with two distinct viral binding
assays: an HA assay at two different temperatures and a
sialylglycopolymer binding assay (Table
4). In both assays, an NA inhibitor,
zanamivir, was included in the incubation mixtures to preclude
any contribution from viral NA enzymatic activity during the assays.
The patterns of hemagglutination at two temperatures indicated that 2EA
(which did not acquire an NA stalk insertion) possesses substantially
lower receptor-binding activity than do the other adapted viruses
(Table 4). Lowering the incubation temperature to 4°C decreased the
dissociation rate of 2EA and increased its relative HA titer to more
than 30 times that observed at 20°C, consistent with the large
reduction in the virus binding affinity to sialylglycopolymers (Table
4). The relative HA titer was the same among the other viruses tested. In contrast to results of the hemagglutination test, we observed several distinctions in the receptor-binding properties of the adapted viruses in assays with specific polymers. In particular, 0EA
displayed a slight decrease in affinity for both 3'SL-PAA and
6'SLN-PAA, while 21EA bound less avidly only to 6'SLN-PAA.
In principle, the decrease in affinity shown by 2EA could be explained
by incomplete removal of sialic acid from the oligosaccharides on the
viral HA and NA (23) due to a deficit in the NA activity of
this strain (deletion in the stalk). To pursue this possibility, we
treated the viruses with exogenous NA (Vibrio cholerae) and compared the abilities of treated and nontreated viruses to bind sialylglycopolymers. Neither strain showed an increase in binding affinity after NA treatment (data not shown), suggesting that incomplete desialylation of the virus does not account for the low
binding affinity of 2EA. The most plausible explanation is that
acquired mutations in the HA (S146G and R262K in HA1 and, to a lesser
extent, R106K in HA2) specifically contribute to the observed decreased
in 2EA binding affinity for sialic-acid-containing receptors.
 |
DISCUSSION |
We demonstrate that an influenza A virus with restricted growth in
embryonated chicken eggs can acquire replicative competence by either
of two distinct mechanisms: restoration of the NA stalk by RNA-RNA
recombination or a decrease in viral (HA) binding affinity to
sialylglycoconjugates. Both mechanisms of adaptation involve interplay
between the NA and HA, two virion glycoproteins needed for viral
attachment to and release from host cells. Of 10 adapted strains of SD0
(an A/WSN/33 mutant with a truncated NA stalk) examined, five underwent
RNA-RNA recombination involving three separate viral RNA segments (PB1,
PB2, and NP). Since the parental virus does not grow efficiently in
eggs, we reasoned that insertions into the NA stalk through
recombination of RNA segments increased accessibility of the NA
enzymatic pocket, and hence the enzyme's receptor-destroying
activities. One of the five noninserted adapted strains (2EA) showed a
decrease in HA binding affinity for sialic acid substrates, presumably
compensating for a defect in functional sialidase activity due to a
deletion in the NA stalk, thereby preventing virion aggregation. These
findings emphasize the importance of HA-NA interplay in the replicative
capacity of influenza A viruses.
Others have reported RNA-RNA recombination during the adaptation of
influenza A viruses (2, 12, 24). Our results are consistent
with theirs (2, 12, 24) in that the mechanism appears to
operate through copy choice, nonhomologous RNA-RNA recombination due to
polymerase jumping during viral RNA transcription. Since no consensus
motifs have emerged from the inserted sequences, the mechanism does not
appear to be specific. It appears unlikely that the RNA-RNA
recombination frequency is inherently greater in the NA stalk region;
rather, the insertions seem to be selected by the growth restriction
(low viral NA function) imposed on the virus in embryonated eggs.
Indeed, we suggest that any gene segment could participate in
recombination with any sequence inserted into the NA stalk; thus,
RNA-RNA recombination during influenza A virus replication may occur
more often than previously thought. In this study, we only examined the
NA and HA genes because the initial virus used for egg adaptation was
defective in NA activity. Whether mutations (such as mutator mutations
[26, 27]) occurred in the polymerase genes of these
strains, which might have enhanced the recombination frequency, is
unknown. Also, involvement of other viral gene products in the
adaptation process is unknown, since sequence analysis was not
performed for all gene segments.
Castrucci et al. (6) have shown that the longer the NA, the
better the virus replicates in eggs. Our findings substantiate this
observation and additionally show that although the NA stalk presumably
contains 24 amino acids, a minimum of 10 in this region is sufficient
for growth adaptation in eggs. Although new sequences were acquired
early in the adaptation process, at passage 4 the resulting mutant did
not begin to replicate efficiently until several passages later. This
suggests that insertions in the NA gene are not by themselves
sufficient for adaptation and that additional mutations are needed for
full conversion, as discussed below.
All egg-adapted viruses, and 2EA in particular, displayed changes in
their receptor-binding properties, regardless of the type of sialic
acid linkage displayed by the sialylglycopolymers. Among the three HA
mutations we identified (Table 3), the Ser-to-Gly substitution at
residue 146 is most likely responsible for the decrease in affinity.
146Ser is conserved among most of the 15 known HA subtypes
(22), suggesting that a mutation at this position could
alter HA function. In the three-dimensional model of X31 HA, residue
146 lies immediately proximal to residue 136, which participates in van
der Waals contacts and hydrogen bond formation with the carboxylic
group of sialic acids (30). All of these interactions can
contribute significantly to HA binding affinity. Thus, a mutation at
residue 146 could decrease the affinity for sialic acid, thereby
inhibiting aggregation of viral particles during infection and budding
of progeny particles. Of course, any acquired HA mutations must reduce
virus affinity for sialic acid without completely abrogating sialic
acid binding, which is required for virus entry into the host cell.
It is interesting that HA mutations are also important for replication
of zanamivir-resistant variants (10, 19). Resistant mutants
selected in the presence of zanamivir contained substitutions in the HA
that decreased the molecule's affinity for sialylglycopolymers. These
variants emerge during the first stages of adaptation, after which
mutations in the NA that decrease enzyme sensitivity to zanamivir
emerge and outgrow the parental virus. These results are compatible
with ours and further demonstrate the functional relationship between
HA and NA activities.
Elucidating the mechanisms of influenza virus adaptation to restricted
hosts is essential to understanding the molecular basis for the
emergence of new strains, especially those implicated in global
outbreaks. If we could understand how viruses adapt to otherwise
replication-incompetent hosts, we might be in a position to target
antiviral therapies to the adapted strains. Results of the present
study promote this aim by demonstrating the critical role of balanced
HA-NA activities in efficient replication of influenza A viruses and by
identifying the mechanisms operating to achieve this balance of protein activity.
 |
ACKNOWLEDGMENTS |
We thank Robert Webster for providing the monoclonal antibodies
to the HA and NA of the WSN virus.
This work was supported in part by Public Health Service research
grants from the National Institute of Allergy and Infectious Diseases,
Cancer Center Support (CORE) grant CA-21765, and the American Lebanese
Syrian Associated Charities (ALSAC). This work was also supported by an
American Lung Association (Memphis, Tenn., chapter) research grant to
L.J.M. M.N.M. was supported by a Karnofsky fellowship from St. Jude's
Children's Research Hospital.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin
Madison, 2015 Linden Dr. West, Madison, WI 53706. Phone: (608) 265-4925. Fax: (608) 265-5622. E-mail:
kawaokay{at}svm.vetmed.wisc.edu.
Present address: Department of Immunology and Rheumatology, Merck
Research Laboratories, Rahway, NJ 07065.
 |
REFERENCES |
| 1.
|
Air, G. M., and W. G. Laver.
1989.
The neuraminidase of influenza virus.
Proteins Struct. Funct. Genet.
6:341-356[CrossRef][Medline].
|
| 2.
|
Bergmann, M.,
A. Garcia-Sastre, and P. Palese.
1992.
Transfection-mediated recombination of influenza A virus.
J. Virol.
66:7576-7580[Abstract/Free Full Text].
|
| 3.
|
Blick, T. J.,
A. Sahasrabudhe,
M. McDonald,
I. J. Owens,
P. J. Morley,
R. J. Fenton, and J. L. McKimm-Breschkin.
1998.
The interaction of neuraminidase and hemagglutinin mutations in influenza virus resistance to 4-guanidino-Neu5Ac2en.
Virology
246:95-103[CrossRef][Medline].
|
| 4.
|
Bovin, N. V.,
E. Y. Korchagina,
T. V. Zemlyanukhina,
N. E. Byramova,
O. E. Galanina,
A. E. Zemlyakov,
A. E. Ivanov,
V. P. Zubov, and L. V. Mochalova.
1993.
Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides.
Glycoconj. J.
10:142-151[CrossRef][Medline].
|
| 5.
|
Castrucci, M. R.,
P. Bilsel, and Y. Kawaoka.
1992.
Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase.
J. Virol.
66:4647-4653[Abstract/Free Full Text].
|
| 6.
|
Castrucci, M. R., and Y. Kawaoka.
1993.
Biologic importance of neuraminidase stalk length in influenza A virus.
J. Virol.
67:759-764[Abstract/Free Full Text].
|
| 7.
|
Colman, P. M.,
W. G. Laver,
J. N. Varghese,
A. T. Baker,
P. A. Tulloch,
G. M. Air, and R. G. Webster.
1987.
The three-dimensional structure of a complex of influenza virus neuraminidase and an antibody.
Nature (London)
326:358-363[CrossRef][Medline].
|
| 8.
|
Crecelius, D. M.,
C. M. Deom, and I. T. Schulze.
1984.
Biological properties of a hemagglutinin mutant of influenza virus selected by host cells.
Virology
139:164-177[CrossRef][Medline].
|
| 9.
|
Gambaryan, A. S., and M. N. Matrosovich.
1992.
A solid-phase enzyme-linked assay for influenza virus receptor-binding activity.
J. Virol. Methods
39:111-123[CrossRef][Medline].
|
| 10.
|
Gubareva, L. V.,
R. C. Bethell,
G. J. Hart,
K. G. Murti, and R. G. Webster.
1996.
Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.
J. Virol.
70:1818-1827[Abstract].
|
| 11.
|
Hanson, J. E.,
N. K. Sauter,
J. J. Skehel, and D. C. Wiley.
1992.
Proton nuclear magnetic resonance studies of the binding of sialosides to intact influenza virus.
Virology
189:525-533[CrossRef][Medline].
|
| 12.
|
Khatchikian, D.,
M. Orlich, and R. Rott.
1989.
Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus.
Nature (London)
340:156-157[CrossRef][Medline].
|
| 13.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 14.
|
Lamb, R.
1983.
The influenza virus RNA segments and their encoded proteins, p. 26-69.
In
P. Palese, and D. W. Kingsbury (ed.), Genetics of influenza viruses. Springer-Verlag, Vienna, Austria.
|
| 15.
|
Lamb, R. A., and P. W. Choppin.
1983.
The gene structure and replication of influenza virus.
Annu. Rev. Biochem.
52:467-506[CrossRef][Medline].
|
| 16.
|
Lamb, R. A., and R. M. Krug.
1996.
Orthomyxoviridae: the viruses and their replication, p. 1353-1445.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 17.
|
Liu, C.,
M. C. Eichelberger,
R. W. Compans, and G. M. Air.
1995.
Influenza type A virus neuraminidase does not play a role in virus entry, replication, assembly, or budding.
J. Virol.
69:1099-1106[Abstract].
|
| 18.
|
Luo, G.,
J. Chung, and P. Palese.
1993.
Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions.
Virus Res.
29:141-153[CrossRef][Medline].
|
| 19.
|
McKimm-Breschkin, J. L.,
T. J. Blick,
A. Sahasrabudhe,
T. Tiong,
D. Marshall,
G. J. Hart,
R. C. Bethell, and C. R. Penn.
1996.
Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
Antimicrob. Agents Chemother.
40:40-46[Abstract].
|
| 20.
|
McKimm-Breschkin, J. L.,
A. Sahasrabudhe,
T. J. Blick,
M. McDonlad,
P. M. Colman,
J. H. Grahm,
R. C. Bethell, and J. N. Varghese.
1998.
Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
J. Virol.
72:2456-2462[Abstract/Free Full Text].
|
| 21.
|
Mitnaul, L.,
M. R. Castrucci,
K. G. Murti, and Y. Kawaoka.
1996.
The cytoplasmic tail of influenza neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.
J. Virol.
70:873-879[Abstract].
|
| 22.
|
Nobusawa, E.,
T. Aoyama,
H. Kato,
Y. Suzuki,
Y. Tateno, and K. Nakajima.
1991.
Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.
Virology
182:475-485[CrossRef][Medline].
|
| 23.
|
Ohuchi, M.,
A. Feldmann,
R. Ohuchi, and H. D. Klenk.
1995.
Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity.
Virology
212:77-83[CrossRef][Medline].
|
| 24.
|
Orlich, M.,
H. Gottwald, and R. Rott.
1994.
Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus.
Virology
204:462-465[CrossRef][Medline].
|
| 25.
|
Palese, P.,
K. Tobita,
M. Ueda, and R. W. Compans.
1974.
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.
Virology
61:397-410[CrossRef][Medline].
|
| 26.
|
Scholtissek, C.,
S. Ludwig, and W. M. Fitch.
1993.
Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages.
Arch. Virol.
131:237-250[CrossRef][Medline].
|
| 27.
|
Suárez, P.,
J. Valcárcel, and J. Ortín.
1992.
Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants.
J. Virol.
66:2491-2494[Abstract/Free Full Text].
|
| 28.
|
Varghese, J. N.,
W. G. Laver, and P. M. Colman.
1983.
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9Å resolution.
Nature
303:35-40[CrossRef][Medline].
|
| 29.
|
von Itzstein, M.,
W.-Y. Wu,
G. B. Kok,
M. S. Pegg,
J. C. Dyason,
B. Jin,
T. Van Phan,
M. L. Smythe,
H. F. White,
S. W. Oliver,
P. M. Colman,
J. N. Varghese,
D. M. Ryan,
J. M. Woods,
R. C. Bethell,
V. J. Hotham,
J. M. Cameron, and C. R. Penn.
1993.
Rational design of potent sialidase-based inhibitors of influenza virus replication.
Nature
363:418-423[CrossRef][Medline].
|
| 30.
|
Weis, W.,
J. H. Brown,
S. Cusack,
J. C. Paulson,
J. J. Skehel, and D. C. Wiley.
1988.
Structure of the influenza virus hemagglutinin complexed with its receptor, sialic acid.
Nature
333:426-431[CrossRef][Medline].
|
Journal of Virology, July 2000, p. 6015-6020, Vol. 74, No. 13
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wasilenko, J. L., Lee, C. W., Sarmento, L., Spackman, E., Kapczynski, D. R., Suarez, D. L., Pantin-Jackwood, M. J.
(2008). NP, PB1, and PB2 Viral Genes Contribute to Altered Replication of H5N1 Avian Influenza Viruses in Chickens. J. Virol.
82: 4544-4553
[Abstract]
[Full Text]
-
Korteweg, C., Gu, J.
(2008). Pathology, Molecular Biology, and Pathogenesis of Avian Influenza A (H5N1) Infection in Humans. Am. J. Pathol.
172: 1155-1170
[Abstract]
[Full Text]
-
Pappas, C., Aguilar, P. V., Basler, C. F., Solorzano, A., Zeng, H., Perrone, L. A., Palese, P., Garcia-Sastre, A., Katz, J. M., Tumpey, T. M.
(2008). Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. USA
105: 3064-3069
[Abstract]
[Full Text]
-
Shin, J.-Y., Song, M.-S., Lee, E. H., Lee, Y.-M., Kim, S.-Y., Kim, H. K., Choi, J.-K., Kim, C.-J., Webby, R. J., Choi, Y.-K.
(2006). Isolation and Characterization of Novel H3N1 Swine Influenza Viruses from Pigs with Respiratory Diseases in Korea. J. Clin. Microbiol.
44: 3923-3927
[Abstract]
[Full Text]
-
Landolt, G. A., Karasin, A. I., Schutten, M. M., Olsen, C. W.
(2006). Restricted Infectivity of a Human-Lineage H3N2 Influenza A Virus in Pigs Is Hemagglutinin and Neuraminidase Gene Dependent. J. Clin. Microbiol.
44: 297-301
[Abstract]
[Full Text]
-
Giannecchini, S., Campitelli, L., Calzoletti, L., De Marco, M. A., Azzi, A., Donatelli, I.
(2006). Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. J. Gen. Virol.
87: 171-175
[Abstract]
[Full Text]
-
Yen, H.-L., Herlocher, L. M., Hoffmann, E., Matrosovich, M. N., Monto, A. S., Webster, R. G., Govorkova, E. A.
(2005). Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility. Antimicrob. Agents Chemother.
49: 4075-4084
[Abstract]
[Full Text]
-
Mishin, V. P., Novikov, D., Hayden, F. G., Gubareva, L. V.
(2005). Effect of Hemagglutinin Glycosylation on Influenza Virus Susceptibility to Neuraminidase Inhibitors. J. Virol.
79: 12416-12424
[Abstract]
[Full Text]
-
Lu, B., Zhou, H., Ye, D., Kemble, G., Jin, H.
(2005). Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse Genetics. J. Virol.
79: 6763-6771
[Abstract]
[Full Text]
-
Jackson, D., Barclay, W., Zurcher, T.
(2005). Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother
55: 162-169
[Abstract]
[Full Text]
-
Hulse, D. J., Webster, R. G., Russell, R. J., Perez, D. R.
(2004). Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens. J. Virol.
78: 9954-9964
[Abstract]
[Full Text]
-
Tumpey, T. M., Garcia-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Basler, C. F.
(2004). Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA
101: 3166-3171
[Abstract]
[Full Text]
-
Spann, K. M., Collins, P. L., Teng, M. N.
(2003). Genetic Recombination during Coinfection of Two Mutants of Human Respiratory Syncytial Virus. J. Virol.
77: 11201-11211
[Abstract]
[Full Text]
-
Watanabe, T., Watanabe, S., Noda, T., Fujii, Y., Kawaoka, Y.
(2003). Exploitation of Nucleic Acid Packaging Signals To Generate a Novel Influenza Virus-Based Vector Stably Expressing Two Foreign Genes. J. Virol.
77: 10575-10583
[Abstract]
[Full Text]
-
Horimoto, T., Takada, A., Iwatsuki-Horimoto, K., Hatta, M., Goto, H., Kawaoka, Y.
(2003). Generation of Influenza A Viruses with Chimeric (Type A/B) Hemagglutinins. J. Virol.
77: 8031-8038
[Abstract]
[Full Text]
-
Gubareva, L. V., Nedyalkova, M. S., Novikov, D. V., Murti, K. G., Hoffmann, E., Hayden, F. G.
(2002). A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. J. Gen. Virol.
83: 2683-2692
[Abstract]
[Full Text]
-
Tumpey, T. M., Suarez, D. L., Perkins, L. E. L., Senne, D. A., Lee, J.-g., Lee, Y.-J., Mo, I.-P., Sung, H.-W., Swayne, D. E.
(2002). Characterization of a Highly Pathogenic H5N1 Avian Influenza A Virus Isolated from Duck Meat. J. Virol.
76: 6344-6355
[Abstract]
[Full Text]
-
Tsuchiya, E., Sugawara, K., Hongo, S., Matsuzaki, Y., Muraki, Y., Li, Z.-N., Nakamura, K.
(2002). Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J. Gen. Virol.
83: 1137-1146
[Abstract]
[Full Text]
-
Kobasa, D., Wells, K., Kawaoka, Y.
(2001). Amino Acids Responsible for the Absolute Sialidase Activity of the Influenza A Virus Neuraminidase: Relationship to Growth in the Duck Intestine. J. Virol.
75: 11773-11780
[Abstract]
[Full Text]
-
Govorkova, E. A., Leneva, I. A., Goloubeva, O. G., Bush, K., Webster, R. G.
(2001). Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses. Antimicrob. Agents Chemother.
45: 2723-2732
[Abstract]
[Full Text]
-
Hughes, M. T., McGregor, M., Suzuki, T., Suzuki, Y., Kawaoka, Y.
(2001). Adaptation of Influenza A Viruses to Cells Expressing Low Levels of Sialic Acid Leads to Loss of Neuraminidase Activity. J. Virol.
75: 3766-3770
[Abstract]
[Full Text]